Evolution of Psychoactive Substances Consumption in Connection With COVID-19 Containment

Completed

• Conditions: COVID-19; Addiction, Substance

• Registration Number: NCT04343339
• Lead Sponsor: University Hospital, Montpellier

Brief Summary

The current containment linked to COVID-19 will have consequences for people suffering from addiction and there is a risk of overdoses when the containment ends. So the investigators hypothesize that this health crisis is an opportunity to develop risk reduction and access to care for vulnerable people who lives with an addiction.

The main objective of this study is to describe the changes in the psychoactive substances consumption during the containment in people suffering from addiction. The secondary objectives are to describe the evolution at 1 month from the end of the containment of problematic consumption and the level of access to care of these users

Detailed Description

Not available

Study Timeline

• Status Verified: 2020-04
• Study Start: 2020-04-08
• Study First Submitted: 2020-04-08
• Study First Submitted QC: 2020-04-08
• Study First Posted: 2020-04-13
• Primary Completion: 2020-07-30
• Study Completion: 2020-09-30
• Last Update Submitted: 2020-10-06
• Last Update Posted: 2020-10-08

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 100

Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Evolution of consumption	1 month after confinmant	measurement of the difference in drugs consumption caused by containment (delta)

Secondary Outcome Measures

Name	Time	Method
health care access	1 month after confinmant	number of drug users referred to care (%)

Trial Locations

Locations (1)

Uhmontpellier; 🇫🇷 Montpellier, France